Trump Slams EU Trade Practices, Announces Drug Price Cuts

President Trump's announcement of an executive order to lower drug costs has sparked debate. He stated, "The European Union is in many ways nastier than China." This statement came as he highlighted the significant cost difference of prescription drugs in the US compared to other countries. The President also emphasized that pharmaceutical companies generate a large portion of their profits within the American market. This assertion raises questions about trade policies and healthcare costs. The executive order aims to address the high prices, but its impact remains to be seen. Experts are divided on the effectiveness of this approach, with some expressing skepticism about its potential to significantly lower costs. The situation underscores the complex interplay between trade, healthcare, and political maneuvering on a global scale.